Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
3,018.76
2,793.96
2,393.61
2,212.30
2,093.67
1,992.52
1,626.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,018.76
2,793.96
2,393.61
2,212.30
2,093.67
1,992.52
1,626.37
Raw Material Cost
1,882.67
1,773.52
1,536.94
1,416.48
1,302.00
1,329.55
1,147.21
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
241.09
258.60
210.63
158.38
136.32
146.00
168.21
Selling and Distribution Expenses
526.83
476.44
429.68
399.70
365.50
326.73
289.60
Other Expenses
-5.49
-6.79
-4.67
3.73
6.55
3.39
1.98
Total Expenditure (Excl Depreciation)
2,595.67
2,440.67
2,130.57
2,011.87
1,869.36
1,836.21
1,624.86
Operating Profit (PBDIT) excl Other Income
423.1
353.29999999999995
263
200.39999999999998
224.3
156.3
1.5
Other Income
22.81
-45.74
7.93
9.43
14.97
19.06
3.76
Operating Profit (PBDIT)
669.47
543.74
500.37
450.04
472.69
415.26
212.51
Interest
241.09
258.60
210.63
158.38
136.32
146.00
168.21
Exceptional Items
-65.60
-103.96
-100.61
-299.61
-71.60
-65.16
-57.31
Gross Profit (PBDT)
1,136.09
1,020.44
856.66
795.82
791.66
662.97
479.16
Depreciation
223.57
236.19
229.40
240.18
233.41
239.88
207.24
Profit Before Tax
139.21
-55.01
-40.27
-248.13
31.37
-35.78
-220.24
Tax
11.28
18.86
8.45
6.66
11.20
-104.36
383.33
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
72.06
-116.89
-83.99
-129.99
10.62
91.06
-361.92
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
72.06
-116.89
-83.99
-129.99
10.62
91.06
-361.92
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
55.88
43.01
35.27
-124.80
9.55
-22.48
-241.66
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
127.93
-73.88
-48.72
-254.79
20.17
68.58
-603.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
-70.79
-109.27
19.78
298.42
360.34
303.27
232.01
Earnings per share (EPS)
0.22
-0.38
-0.48
-0.86
0.07
0.61
-2.74
Diluted Earnings per share
0.22
-0.38
-0.48
-0.86
0.07
0.61
-2.74
Operating Profit Margin (Excl OI)
14.02%
12.64%
10.99%
9.06%
10.71%
7.85%
0.09%
Gross Profit Margin
12.02%
6.48%
7.9%
-0.36%
12.65%
10.24%
-0.8%
PAT Margin
2.39%
-4.18%
-3.51%
-5.88%
0.51%
4.57%
-22.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 8.05% vs 16.73% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 273.07% vs -51.75% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 9.70% vs 19.72% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -6.77% vs 22.79% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Amneal Pharmaceuticals, Inc. With
Figures in Million
Consolidate Annual Results
Change(USD)
Change(%)
Net Sales
3,018.76
0
3,018.76
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,018.76
0
3,018.76
Raw Material Cost
1,882.67
0
1,882.67
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
241.09
0
241.09
Selling and Distribution Expenses
526.83
0
526.83
Other Expenses
-5.49
0.00
-5.49
Total Expenditure (Excl Depreciation)
2,595.67
0
2,595.67
Operating Profit (PBDIT) excl Other Income
423.09
0.00
423.09
Other Income
22.81
0
22.81
Operating Profit (PBDIT)
669.47
0
669.47
Interest
241.09
0
241.09
Exceptional Items
-65.60
0
-65.60
Gross Profit (PBDT)
1,136.09
0
1,136.09
Depreciation
223.57
0
223.57
Profit Before Tax
139.21
0
139.21
Tax
11.28
0
11.28
Provisions and contingencies
0
0
0.00
Profit After Tax
72.06
0
72.06
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
72.06
0
72.06
Share in Profit of Associates
0
0
0.00
Minority Interest
55.88
0
55.88
Other related items
0.00
0.00
0.00
Consolidated Net Profit
127.93
0
127.93
Equity Capital
0
0
0.00
Face Value
0.01
0
0.00
Reserves
-70.79
0
-70.79
Earnings per share (EPS)
0.22
0
0.22
Diluted Earnings per share
0.22
0
0.22
Operating Profit Margin (Excl OI)
14.02%
0%
0.00
14.02%
Gross Profit Margin
12.02%
0%
0.00
12.02%
PAT Margin
2.39%
0%
0.00
2.39%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 301.88 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 8.05% vs 16.73% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 12.79 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 273.07% vs -51.75% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 64.67 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 9.70% vs 19.72% in Dec 2024
Annual - Interest
Interest 24.11 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -6.77% vs 22.79% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.02%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






